Roger Keiling
Impact in
- Obstetrics and Gynecology top 2%
- Endometrial and Cervical Cancer Treatments
- Oncology top 10%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
Papers in
- Oncology 19
- Cancer Treatment and Pharmacology 12
-
- Breast Cancer Treatment Studies 8
- Co-authors
- Pierre Kerbrat (4 shared papers)S Schraub (6 shared papers)P. Fumoleau (3 shared papers)F.M. Delgado (1 shared paper)Constantin Vrousos (5 shared papers)T. Delozier (1 shared paper)E García-Giralt (1 shared paper)Marie-Thérèse Closon (1 shared paper)
In The Last Decade
Roger Keiling
26 papers receiving 675 citations
Peers
Comparison fields: 5 of 54
- Obstetrics and Gynecology 232
- Oncology 323
- Cancer Research 98
- Reproductive Medicine 55
- Pathology and Forensic Medicine 52
Countries citing papers authored by Roger Keiling
This map shows the geographic impact of Roger Keiling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Keiling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Keiling more than expected).
Fields of papers citing papers by Roger Keiling
This network shows the impact of papers produced by Roger Keiling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Keiling. The network helps show where Roger Keiling may publish in the future.
Co-authors
The 25 scholars most cited alongside Roger Keiling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 297 | |
| 2 | 1988 | 149 | |
| 3 | 1987 | 61 | |
| 4 | 1985 | 38 | |
| 5 | 1992 | 34 | |
| 6 | 1993 | 22 | |
| 7 | 1984 | 20 | |
| 8 | 1986 | 19 | |
| 9 | 1988 | 14 | |
| 10 | 1989 | 13 | |
| 11 | Preoperative chemotherapy in the treatment of inflammatory breast cancer. | 1985 | 12 |
| 12 | Phase II clinical evaluation of doxifluridine. | 1986 | 11 |
| 13 | 1984 | 9 | |
| 14 | 1981 | 8 | |
| 15 | Variations in the percentages of lymphocyte subtypes during the menstrual cycle in women. | 1988 | 7 |
| 16 | [Thorotrast infection into the maxillary sinus: appearance of a malpighien epithelioma 15 years later]. | 1955 | 5 |
| 17 | 2000 | 5 | |
| 18 | 1985 | 4 | |
| 19 | 1993 | 4 | |
| 20 | [An analog of gonadoliberin in the treatment of prostatic carcinoma]. | 1984 | 3 |
About Roger Keiling
Roger Keiling is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Obstetrics and Gynecology and Cardiology and Cardiovascular Medicine, having authored 36 papers that have together received 750 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (12 papers), Breast Cancer Treatment Studies (8 papers), Chemotherapy-induced cardiotoxicity and mitigation (5 papers), Endometrial and Cervical Cancer Treatments (4 papers), Lung Cancer Treatments and Mutations (4 papers), Colorectal and Anal Carcinomas (3 papers), Cervical Cancer and HPV Research (3 papers) and Prostate Cancer Treatment and Research (3 papers). The work is most often cited by research in Obstetrics and Gynecology (232 citations), Oncology (323 citations), Cancer Research (98 citations), Reproductive Medicine (55 citations) and Pathology and Forensic Medicine (52 citations). Roger Keiling has collaborated with scholars based in France, Belgium and Ireland. Frequent co-authors include Pierre Kerbrat, S Schraub, P. Fumoleau, F.M. Delgado, Constantin Vrousos, T. Delozier, E García-Giralt, Marie-Thérèse Closon, M. Namer and Alain Monnier. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, European Journal of Cancer, Cancer, Journal of Clinical Oncology and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.